ESC 365 - The advantages of using transtelephonic ECG monitoring device in outpatients with paroxysmal form of atrial fibrillation

ESC2025 Premium Access

The advantages of using transtelephonic ECG monitoring device in outpatients with paroxysmal form of atrial fibrillation

Session: Cardiac rhythm disorders: devices, drugs, and outcomes

Topic: Wearables and m-Health

Speaker: Mrs M. Hamidzoda (Dushanbe, TJ)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Mrs Manizha Hamidzoda

International Clinic Avicenna, Dushanbe (Tajikistan)

0 follower

5 more presentations in this session

Nearly nine year follow-up data on a leadless pacing system real life experience in comparison to data of the prospective trial

Speaker: Doctor S. Winter (Cologne, DE)

Omega-3 Fatty Acids reduce rate and QT-interval, but increase electrical instability in cardiomyocytes

Speaker: Doctor C. Balbi (Zurich, CH)

HARBOR-AF: a multicentre, open-label, dose escalation study of the efficacy, safety, and tolerability of budiodarone for the treatment of subjects with paroxysmal atrial fibrillation

Speaker: Doctor C. Flynn (San Francisco Bay, US)

Guidelines and heartlines: evaluating procainamide use at a large academic medical center

Speaker: Doctor T. Ahuja (New York, US)

Trends in arrhythmia-related mortality among adults with hyperthyroidism in the U.S. from 1999 to 2020: A CDC WONDER analysis

Speaker: Miss O. Dairo (London, GB)

Access the full session

Cardiac rhythm disorders: devices, drugs, and outcomes

Speakers: Mrs M. Hamidzoda, Doctor S. Winter, Doctor C. Balbi, Doctor C. Flynn, Doctor T. Ahuja...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources